Related Experiment Video
Updated: Aug 20, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Clinical characteristics of persistent lone atrial fibrillation in the RACE study
Michiel Rienstra1, Vincent E Hagens, Dirk J Van Veldhuisen
1Department of Cardiology, Northern Center of Healthcare Research, University Hospital, Groningen, The Netherlands.
Insights
Lone atrial fibrillation (AF) patients experienced fewer symptoms and better quality of life than those with structural heart disease. Despite lacking underlying conditions, lone AF still carries risks of bleeding and thromboembolism.
Area of Science:
- Cardiology
- Clinical Electrophysiology
Background:
- Atrial fibrillation (AF) management strategies vary, impacting patient outcomes.
- Distinguishing lone AF from AF with underlying structural heart disease is crucial for risk stratification.
Purpose of the Study:
- To compare demographics, clinical outcomes, and quality of life in patients with lone AF versus those with AF and structural heart disease.
- To assess the specific risks associated with lone AF.
Main Methods:
- Analysis of data from the RAte Control versus Electrical cardioversion for persistent atrial fibrillation (RACE) study.
- Randomized controlled trial comparing rate versus rhythm control in 522 patients.
- Subgroup analysis of 89 patients with lone AF.
Main Results:
- Lone AF patients were younger and reported less fatigue and dyspnea.
- Quality of life scores were higher in lone AF patients, comparable to healthy controls.
- Cardiovascular endpoints occurred in 10% of lone AF patients (bleeding, thromboembolism, pacemaker implantation), with no heart failure or severe antiarrhythmic drug events.
Conclusions:
- Lone AF is associated with a better quality of life and fewer symptoms compared to AF with structural heart disease.
- Despite the absence of overt cardiovascular disease, lone AF patients face significant risks of bleeding and thromboembolic events.
Abstract:
In the RAte Control versus Electrical cardioversion for persistent atrial fibrillation (RACE) study, 522 patients were randomized to either rate or rhythm control therapy. Lone atrial fibrillation (AF) was present in 89 patients. Demographics, cardiovascular mortality and morbidity, and quality of life were compared between patients with lone AF and those with underlying structural heart disease. Patients with lone AF were significantly younger (65 +/- 10 vs 69 +/- 8 years) and had fewer complaints of fatigue (p = 0.01) and dyspnea (p = 0.005). With lone AF, quality-of-life scores were higher on almost all 8 Medical Outcomes Study Short-Form health survey questionnaire subscales, and comparable to healthy, age- and gender-matched controls. Mean follow-up was 2.3 +/- 0.6 years. Cardiovascular end points occurred in 9 patients with lone AF (10%), consisting of death (all bleedings) 3%, thromboembolic complications in 3%, nonfatal bleeding in 2%, and pacemaker implantation in 2%, but no heart failure and severe adverse effects due to antiarrhythmic drugs occurred. End points occurred in 95 patients (22%) with underlying diseases. Heart failure and severe adverse effects from drugs did not occur in patients with lone AF in this study. Despite the absence of demonstrable cardiovascular and cerebrovascular disease, lone AF is associated with bleeding and thromboembolism.
Related Concept Videos
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Acute Coronary Syndrome III: Diagnostic Studies
Dysrhythmias III: Characteristics of Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
